FDA staff backs injection to reduce double chin

March 5, 2015 5:19 PM

4 0

FDA staff backs injection to reduce double chin

An injection for "double chin" reduction developed by Kythera Biopharmaceuticals Inc cleared the first hurdle toward approval as U.S. Food and Drug Administration staff concluded the drug's benefits outweighed its risks.

Kythera's stock jumped as much as 25 percent as investors bet on what could be the first approved drug in the United States to reduce localized fat deposits.

Also read: Senate Clears Bill to Ease FDA Drug and Device Approvals

Read more

To category page

Loading...